Nomura Holdings has launched an internal investigation into its India fixed-income business amid concerns that profits may have been overstated in recent years. According to a recent Bloomberg News report, the Japanese investment bank is scrutinizing whether valuations tied to certain government securities trades were recorded accurately, with a particular focus on STRIPS, or Separate Trading of Registered Interest and Principal Securities. These instruments are often used for long-term investment strategies, and inaccuracies in pricing can significantly impact reported earnings.
Sources familiar with the matter revealed that Nomura’s compliance division began reviewing the valuation and accounting practices of its local primary dealership roughly a month ago. The inquiry aims to determine whether improper methodologies or internal controls may have contributed to inflated profit figures. While the scope of the review has not been publicly detailed, it underscores Nomura’s broader efforts to strengthen oversight and maintain transparency across its global operations.
Nomura Holdings (TYO: 8604), a major player in Japan’s investment banking and securities sector, maintains a strong presence throughout Asian markets, including India. The region is an important growth area for the firm, making the accuracy of financial reporting particularly critical as regulators and investors closely monitor performance. Any findings from the investigation could have implications for internal risk management processes and future business strategies within the firm’s fixed-income division.
As global financial institutions face increasing scrutiny over compliance and valuation standards, Nomura’s proactive review reflects both regulatory expectations and the company’s commitment to maintaining integrity in its financial disclosures. Market participants will be watching closely for updates as the investigation progresses, given its potential impact on Nomura’s reputation and its operations across Asia.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 



